4D Molecular Therapeutics, Inc. Balance Sheet

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Accumulated Depreciation 2.62M3.84M5.33M7.73M11.93M16.59M
Assets
Current Assets
Cash & Equivalents 49.65M276.73M153.00M52.35M249.11M149.34M
Receivables - Net 0.98M1.49M0.05M
Receivables - Other 0.15M0.70M0.70M
Receivables 1.13M1.49M0.75M
Prepaid Assets 1.88M4.44M8.46M6.96M8.36M10.05M
Current Assets 52.51M282.66M256.28M220.51M296.59M434.93M
Non-Current Assets
Property, Plant & Equipment (Net) 5.05M5.07M14.39M22.26M20.13M19.53M
Long-Term Investments 67.65M4.91M10.95M80.58M
Other Non-Current Assets 0.68M0.60M0.60M1.08M0.68M4.26M
Non-Current Assets 5.73M5.67M97.21M41.34M43.30M125.45M
Assets 58.23M288.33M353.49M261.85M339.89M560.38M
Liabilities
Current Liabilities
Accounts Payables 1.74M1.79M4.76M3.32M3.52M4.39M
Payables 1.74M1.79M4.76M3.32M3.52M4.39M
Accumulated Expenses 5.35M8.37M7.74M8.87M12.01M18.87M
Other Accumulated Expenses 0.48M0.49M1.77M0.38M0.10M0.11M
Current Leases 1.23M2.65M3.15M5.64M
Current Deferred Revenue 19.47M19.81M5.09M1.96M0.27M0.26M
Total Current Liabilities 12.96M16.74M16.34M15.73M18.95M29.15M
Non-Current Liabilities
Non-Current Deffered Revenue 13.60M13.23M2.49M1.08M0.97M1.06M
Preferred Stock Liabilities 102.98M
Operating Leases 15.22M13.47M11.52M18.97M
Other Non-Current Liabilities 1.56M1.85M0.21M0.21M0.37M0.41M
Total Non-Current Liabilities 26.66M30.09M34.17M30.30M31.69M49.37M
Total Liabilities 28.22M31.94M34.38M30.51M32.06M49.78M
Shareholder's Equity
Common Equity -72.97M256.39M319.11M231.34M307.83M510.61M
Shareholder's Equity -72.97M256.39M319.11M231.34M307.83M510.61M
Liabilities and Shareholders Equity 58.23M288.33M353.49M261.85M339.89M560.38M
Retained Earnings -79.03M-135.68M-207.00M-314.49M-415.33M-576.20M
Treasury Shares 0.18M0.36M
Shares Outstanding 5.18M26.68M32.22M32.63M43.08M45.79M